Literature DB >> 21162795

[Clinical experiences in the treatment of human multi-organ alveolar echinococcosis by surgery and drugs].

Hai-tao Li1, Ying-mei Shao, Jin-ming Zhao, Bo Ran, Hao Wen.   

Abstract

OBJECTIVE: To explore the approach of operation plus chemotherapy in the treatment and diagnosis of human complicated alveolar echinococcosis (AE) in multi-organs (liver, lung and brain).
METHODS: The clinical data for 17 cases of alveolar echinococcosis were reviewed by a follow-up of 1 - 7 years between 2000 and 2009 at our hospital.
RESULTS: Among 17 cases, 8 cases achieved an excellent effect after taking liposomal albendazole, 3 cases received radical hepatectomy and 1 case pneumonectomy with a better effect, 1 case of palliative liver transplantation had lung metastasis and stayed on a long-term therapy of liposomal albendazole. Another case of liver transplantation received a long-term postoperative chemotherapy. And the metastases of lung and brain were found. Three operative cases suffered serious complications in liver and brain and received a long-term chemotherapy. One of them died of serious brain complications after a 6-month follow-up. And one advanced AE patient died at home due to a refusal of any further treatment. Since more than two organs are involved by AE lesion of alveolar echinococcosis, it was rather difficult to diagnose and cure AE radically by complicated surgery. Thus the life quality and long-term survival of patients were seriously endangered.
CONCLUSION: Based on surgical approaches for serious complications and a comprehensive medical therapy, the multi-organ AE patients may have a prolonged survival and an improved clinical outcome.

Entities:  

Mesh:

Year:  2010        PMID: 21162795

Source DB:  PubMed          Journal:  Zhonghua Yi Xue Za Zhi        ISSN: 0376-2491


  3 in total

1.  Chemotherapy in alveolar echinococcosis of multi-organs: what's the role?

Authors:  Haitao Li; Tao Song; Yingmei Shao; Aili Tuergan; Bo Ran; Hao Wen
Journal:  Parasitol Res       Date:  2013-03-19       Impact factor: 2.289

2.  30-yr course and favorable outcome of alveolar echinococcosis despite multiple metastatic organ involvement in a non-immune suppressed patient.

Authors:  Karine Bardonnet; Dominique A Vuitton; Frédéric Grenouillet; Georges A Mantion; Eric Delabrousse; Oleg Blagosklonov; Jean-Philippe Miguet; Solange Bresson-Hadni
Journal:  Ann Clin Microbiol Antimicrob       Date:  2013-01-02       Impact factor: 3.944

3.  Comparative Evaluation of Liposomal Albendazole and Tablet-Albendazole Against Hepatic Cystic Echinococcosis: A Non-Randomized Clinical Trial.

Authors:  Haitao Li; Tao Song; Yingmei Shao; Tuergan Aili; Ayifuhan Ahan; Hao Wen
Journal:  Medicine (Baltimore)       Date:  2016-01       Impact factor: 1.889

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.